Ethical issues confronted in pulmonary clinical trials

Proceedings of the American Thoracic Society

Volumn 4, Issue 2, 2007, Pages 200-205

  Wise, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Research ethics; Smoking cessation

Indexed keywords

METHACHOLINE; NEDOCROMIL; PLACEBO; SALBUTAMOL;

ASTHMA; BENEFICENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL RESEARCH; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HUMAN; JUSTICE; MEDICAL ETHICS; MEDICAL PRACTICE; MORTALITY; PATIENT AUTONOMY; PRACTICE GUIDELINE; RESPIRATORY SYSTEM; REVIEW; SMOKING; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ASTHMA; CLINICAL TRIALS; ETHICS, RESEARCH; HELSINKI DECLARATION; HUMANS; PNEUMONECTOMY; PRACTICE GUIDELINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RESEARCH DESIGN; SMOKING CESSATION; UNITED STATES; UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;

EID: 34248365709     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200701-006GC     Document Type: Review

References (27)

1. Cooper JD, Trulock EP, Triantafillou AN, Patterson GA, Pohl MS, Deloney PA, Sundaresan RS, Roper CL. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995;109:106-116.
2. Tonelli MR, Benditt JO, Albert RK. Clinical experimentation: lessons from lung volume reduction surgery. Chest 1996;110:230-238.
3. Statement of Bruce C. Vladek before the House Ways and Means Committee on Health, April 17, 1997, page 31. Available at: http://commdocs.house.gov/ committees/ways/hwmw105-14.000/hwmw105-14_0f.htm (accessed March 9, 2007).
4. Weinmann GG, Hyatt R. NIH Workshop Report: Evaluation and research in lung volume reduction surgery. Am J Respir Crit Care Med 1996;154:1913-1918.
5. Four Minnesotans in Congress go to bat for Bio-Vascular product; Medicare will not reimburse cost of new surgery that uses Peri-Strip. Star Tribune (Minneapolis, MN) September 23, 1996, Metro Edition, Page 1D.
6. Leary WE. Debating the benefits and costs of major surgery for emphysema. The New York Times May 14, 1996.
7. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001;345:1075-1083.
8. Lee SM, Wise R, Sternberg AL, Tonascia J, Piantadosi S, for the National Emphysema Treatment Trial Research Group. Methodologic issues in terminating enrollment of a subgroup of patients in a multicenter randomized trial. Clin Trials 2004;1:326-338.
9. Kolata G. Medicare says it will pay, but patients say 'no thanks'. March 3, 2006. New York Times.
10. Ramsey SD, Sullivan SD. Evidence, economics, and emphysema: Medicare's long journey with lung volume reduction surgery. A case of science meeting politics. Health Aff 2005;24:55-66.
11. Weinstein JN, Tosteson TD, Lurie JD, Tosteson AN, Hanscom B, Skinner JS, Abdu WA, Hilibrand AS, Boden SD, Deyo RA. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA 2006;296:2441-2450.
12. Flum DR. Interpreting surgical trials with subjective outcomes: Avoiding UnSPORTsmanlike conduct. JAMA 2006;296:2483-2485.
13. Holton T. FDA uneasy about placebo revision. Nat Med 2001;7:7.
14. Lewis JA, Jonsson B, Kreutz G, Sampaio C, van Zwieten-Boot B. Placebo-controlled trials and the Declaration of Helsinki. Lancet 2002;359:1337-1340.
15. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003;327:1459-1461.
16. Gibson PG, Wong BJ, Hepperle MJ, Kline PA, Girgis-Gabardo A, Guyatt G, Dolovich J, Denburg JA, Ramsdale EH, Hargreave FE. A research method to induce and examine amild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 1992;22:525-532.
17. Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF Jr, Sorkness CA, Kraft M, Fish JE, Peters SP, Craig T, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 2001;285:2583-2593.
18. Botkin JR, Clayton E, Nelson R, Wilfond B, Munger MA. Salmeterol and inhaled corticosteroids in patients with persistent asthma. JAMA 2001;286:3075.
19. Miller FG, Shorr AF. Salmeterol and inhaled corticosteroids in patients with persistent asthma. JAMA 2001;286:3075-3076.
20. Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Control Clin Trials 1999;20:91-120.
21. Celli BR, MacNee W; American Thoracic Society/European Respiratory Society Guideline Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
22. Workshop Report. Global Strategy for Diagnosis, Management, and Prevention of COPD, Updated 2005. Available at: www.goldcopd.com (accessed March 8, 2006).
23. Weitzenblum E, Chaouat A. Sleep and chronic obstructive pulmonary disease. Sleep Med Rev 2004;8:281-294.
24. Pauwels RA, Lofdahl CG, Pride NB, Postma DS, Laitinen LA, Ohlsson SV.European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J 1992;5:1254-1261.
25. Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000;343:1902-1909.
26. Berkley S. Thorny issues in the ethics of AIDS vaccine trials. Lancet 2003;362:992.
27. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 1981;305:982-987.